Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma

International Journal of Cancer

Volumn 105, Issue 1, 2003, Pages 41-46

  Viswanathan, Muthusamy ^a   Tsuchida, Nobuo ^b   Shanmugam, Govindaswamy ^a  

^a MADURAI KAMARAJ UNIVERSITY   (India)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

E cadherin; hMLH1; MGMT; Oral squamous cell carcinoma; p15; p16; Promoter hypermethylation

Indexed keywords

GENE PRODUCT; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MLH1; PROTEIN P15; PROTEIN P16; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DNA ISOLATION; GENE INACTIVATION; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; INDIA; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CADHERINS; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CELL CYCLE PROTEINS; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA; DNA METHYLATION; HUMANS; MODELS, GENETIC; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RISK FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0345269743     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11028     Document Type: Article

References (30)

1. 6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 2001;61:939-42.
2. Feinberg AP. Cancer epigenetics takes center stage. Proc Natl Acad Sci USA 2001;98:392-4.
3. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis. Trends Genet 2000;16:168-73.
4. INK4a is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA 1998:95:11891-6.
5. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JJ, Davidson NE, Sidransky D, Baylin SB. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant dna methylation in all human cancers. Cancer Res 1995;55:4525-30.
6. Robertson KD. DNA methylation, methyltransferases, and cancer. Oncogene 2001:20:3139-55.
7. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995;1:686-92.
8. INKB1. Cancer Res 1996;56:722-7.
9. Veigl ML, Kasturi L, Olechnowicz J, Ma A, Lutterbaugh JD, Periasamy S, Li GM, Drummond J, Modrich PL, Sedwick WD, Markowitz SD. Biallelic inactivation of hMLH11 by epigenetic mechanism causing human MSI cancers. Proc Natl Acad Sci USA 1998;95:8698-702.
10. Nakayama S, Sasaki A, Mese H, Alcade RE, Tsuji T, Matsumura T. The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas. Int J Cancer 2001;93:667-73.
11. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-9.
12. Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983;301:89-92.
13. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995;55:4531-5.
14. Ueda T, Abe K, Miura A, Yuzuriha M, Zubair M, Noguchi M, Niwa K, Kawase Y, Kono T, Matsuda Y, Fujimoto H, Shibata H, et al. The paternal methylation imprint of the mouse H19 locus is acquired in the gonocyte stage during foetal testis development. Genes Cells 2000;5:649-59.
15. INK4a gene in resected nonsmall cell lung tumors and exfoliated cells within sputum. Int J Cancer 2002;98:724-31.
16. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994;22:2990-7.
17. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Cancer Res 1996;93:9821-6.
18. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW. Methylight: a high-thoroughput assay to measure DNA methylation. Nucleic Acids Res 2000;28:32e.
19. Melki JR, Vincent PC, Clark SJ. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res 1999:59:3730-40.
20. 6-methylguanine-DNA-methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res 2001;61:4689-92.
21. Munirajan AK, Mohanprasad BKC, Shanmugam G, Tsuchida N. Detection of a rare point mutation at codon 59 and relatively high incidence of H-ras mutation in Indian oral cancer. Int J Oncol 1998;13:971-4.
22. Munirajan AK, Ishii YT, Mohanprasad BKC, Hirano Y, Munakata N, Shanmugam G, Tsuchida N. p53 gene mutations in oral carcinomas from India. Int J Cancer 1996;66:297-300.
23. Kannan K, Munirajan AK, Krishnamurthy J, Bhuvarahamurthy V, Mohanprasad BKC, Panishankar KH, Tsuchida N, Shanmugam G. Low incidence of p53 mutations in betel quid and tobacco chewing-associated oral squamous carcinoma from India. Int J Oncol 1999;15:1133-6.
24. INK4A gene in oral squamous cell carcinomas. Cancer Lett 2001;163:221-8.
25. ARF exon 1β of the INK4a locus in oral squamous cell carcinomas of Indians. Oral Oncol 2001;37:341-4.
26. ARF gene mutations are infrequent and are mutually exclusive to p53 mutations in Indian oral squamous cell carcinomas. Int J Oncol 2000;16:585-90.
27. Ishwad CS, Ferrell RE, Rossie KM, Appel BN, Johnson JT, Myers EN, Law JC, Srivastava S, Gollin SM. Microsatellite instability in oral cancer. Int J Cancer 1995;64:332-5.
28. Jin YT, Myers J, Tsai ST, Goepfert H, Batsakis JG, el-Naggar AK. Genetic alterations in oral squamous cell carcinoma of young adults. Oral Oncol 1999;35:251-6.
29. Mahale A, Saranath D. Microsatellite alterations on chromosome 9 in chewing tobacco-induced oral squamous cell carcinomas from India. Oral Oncol 2000;36:199-206.
30. Kannan K, Munirajan AK, Bhuvarahamurhty V, Mohanprasad BKC, Shankar P, Tsuchida N, Shanmugam G. FHIT gene mutations and single nucleotide polymorphism in Indian oral and cervical squamous cell carcinomas. Oral Oncol 2000:36:189-93.